About this trial
29.3% of bacteremias in intensive care units (ICU) are linked to vascular devices, including 7.7% to arterial catheters, with an influence on both morbility and mortality.
It is now accepted that biofilm as a role on bacterial development on inner surface of vascular devices but there is yet a lack of clinical relevant data documenting a causal relation between biofilm formation and bacteremias.
The investigators assume that a better structural and microbiological characterization of arterial catheter biofilm in ICU patients could help preventing bacteremias or have a more specific treatment when it appears.
Eligibility criteria
Qualifiers
Patient or relative informed of the study and having declared their non-objection
Patient over 18 years old
Patient hospitalized in ICU with an arterial catheter
Disqualifiers
Patient unable to express consent
Patient whose collection of the arterial catheter is impossible or for whom storage at 4°C is impossible
Patient with arterial catheter removed outside the usual procedure of the ICU
Patient admitted in ICU with an arterial catheter already in place
Trial design
Treatments tested in this trial
- OCT-BIO-KTA cohort
Treatment groups
Sponsors and collaborators
Centre Hospitalier William Morey - Chalon sur Saône
Lead sponsor
Centre Hospitalier Universitaire Dijon
Collaborator
Centre Hospitalier Macon
Collaborator